Skip to content

Current ratio at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
1.2×+0.2×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
2.1×-1.1×
Guardant Health logo
Guardant HealthGH
4.7×+0.6×
Revvity logo
RevvityRVTY
1.7×-1.9×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
6.7×+4.4×
Labcorp Holdings logo
Labcorp HoldingsLH
1.7×-0.1×

Other financials

Income statement

See full
Revenue$377.3M+1.2%
Gross profit$230.9M-2.9%
Operating income$81.3M-20.3%
Net income$118.4M+62.3%
EPS (diluted)$1.80+76.5%

Balance sheet

See full
Cash & equivalents$500.3M-46.8%
Total debt$627.9M+1.8%
Total equity$1.2B+4.1%
Total assets$2.3B+14.2%

Cash flow

See full
Operating cash flow$125.1M+16.3%
CapEx$3.2M-63.0%
Free cash flow$121.9M+23.3%

Valuation

See full
Market cap$6.76B-26.3%
Enterprise value$6.89B-20.5%
P/E24.2×-10.2×
P/S4.4×-1.6×

Profitability

See full
Gross margin60.5%-3.6pp
Operating margin18.8%-10.7pp
Net margin18%+0.7pp
FCF margin24.4%-6.4pp

Returns & leverage

See full
Return on equity23.5%-1.7pp
Debt / equity0.5×0.0×

Where this comes from

Calculated from Lantheus Holdings’s reported figures.

Based on the most recent quarter.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lantheus Holdings's current ratio?
Lantheus Holdings (LNTH) reported current ratio of 2.8× in Q1 2026.
How has Lantheus Holdings's current ratio changed year-over-year?
Lantheus Holdings's current ratio decreased by 50.7% year-over-year, from 5.7× to 2.8×.
What is the long-term trend for Lantheus Holdings's current ratio?
Over 5 years (2020 to 2025), Lantheus Holdings's current ratio has grown at a 3.4% compound annual growth rate (CAGR), from 2.3× to 2.7×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.